Genentech Directors Urge Stockholders to Reject Roche Deal | Practical Law
An update on a letter sent to stockholders of Genentech by the directors of the company, urging a vote to reject a buyout offer from Roche for $86.50 a share.
An update on a letter sent to stockholders of Genentech by the directors of the company, urging a vote to reject a buyout offer from Roche for $86.50 a share.